Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank57
3Y CAGR-7.2%
5Y CAGR+15.9%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-7.2%/yr
vs +100.6%/yr prior
5Y CAGR
+15.9%/yr
Recent deceleration
Acceleration
-107.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $448.37M | -27.9% |
| 2024 | $621.82M | +28.4% |
| 2023 | $484.18M | -13.7% |
| 2022 | $561.12M | +28.3% |
| 2021 | $437.19M | +103.6% |
| 2020 | $214.71M | +113.7% |
| 2019 | $100.46M | +190.0% |
| 2018 | $34.64M | - |